BBB Bloch

B Bloch

*This is an algorithmically generated author record based on publicly available information.

B Bloch has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 28 February 2000
      • Vol. 418  (1) , 22-32

    Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.

    by I Aubert, I Ghorayeb, E Normand, B Bloch

    The striatum is regulated by dopaminergic inputs from the substantia nigra. Several anatomical studies using in situ hybridization have demonstrated that in rodents, dopamine D1 and D2 receptors are segregated into distinct striatal efferent populations: dopamine D1 receptor into gamma-aminobutyric acid (GABA)/substance P striatonigral neurons, and dopamine D2 receptor into GABA/enkephalin striatopallidal neurons. The existence of such a segregation has not been investigated in primates. Therefore, to quantify the efferent striatal GABAergic neurons in the adult Cynomolgus monkey, we detected GAD67 mRNA expression while considering that only a minority of the GABAergic population is composed of interneurons. To characterize the peptidergic phenotype of the neurons expressing dopamine D1 or D2 receptors, we examined the mRNA coding for these receptors in the striatum at the cellular level using single- and double in situ hybridization with digoxigenin and 35S ribonucleotide probes. Double in situ hybridization demonstrated a high coexpression of dopamine D1 receptor and substance P mRNAs (91-99%) as well as dopamine D2 receptor and preproenkephalin A mRNAs (96-99%) in medium-sized neurons throughout the nucleus caudatus, putamen, and nucleus accumbens. Only a small subpopulation (2-5%) of the neurons that contained dopamine D1 receptor mRNA also expressed dopamine D2 receptor mRNA in all regions. Large-sized neurons known to be cholinergic expressed D2R mRNA. However, within the nucleus basalis of Meynert, the large cholinergic neurons expressed D2R mRNA, but the neurons producing enkephalin expressed neither D1R nor D2R mRNA. These results demonstrate that the striatal organizational pattern of D1 and D2 receptor segregation in distinct neuronal populations described in rodent also exists in primate.


    • 1 November 1995
      • Vol. 41  (7) , 917-23

    Use of non-radioactive probes for mRNA detection by in situ hybridization: interests and applications in the central nervous system.

    by C Le Moine, E Normand, B Bloch

    Non-radioactive probes for in situ hybridization (ISH) are now widely used to detect mRNAs in the central nervous system (CNS) using light and electron microscopy. Many different protocols for the detection of biotinylated or digoxigenin-labelled probes are now available. The advantages and inconveniences of the use of the non-radioactive probes are reviewed in the current work. These aspects are illustrated by some results from first-hand experience in the field of ISH to analyse gene expression and neuronal phenotypes in the hypothalamus and the basal ganglia. A very sensitive procedure for the simultaneous detection of two mRNAs with cRNA probes have been detailed and using in particular digoxigenin-labelled probes.


    • 27 November 1991
      • Vol. 20  (40) , 2004-6

    [Tumor necrosis factor in graft rejection. In situ hybridization study].

    by D Morel, E Normand, C Lemoine, J P Merlio, L Potaux, M Aparicio, B Bloch

    The development of necrosis and macrophage infiltration increases the risk of renal graft rejection. But the macrophages secrete the alpha form of the tumour necrosing factor (TNF) which is also involved in several immunologic and inflammatory phenomena. We therefore studied the expression of the gene TNF alpha by in situ hybridization during advanced stage rejection after renal transplantation: the grafts were infiltrated with macrophage-like cells expressing the mRNA of the TNF alpha gene, particularly deep in the cortex and in the medulla. These cells then secrete the TNF alpha molecule since they are recognized by anti-TNF alpha antibodies. These antibodies also recognize certain other glomerular endothelial and tubular epithelial cells which do not express the TNF alpha gene: these cells are undoubtedly the TNF target cells. These findings confirm the synthesis of TNF alpha in advanced stage renal graft rejection.